- Joined
- Feb 21, 2015
- Messages
- 5,970
- Points
- 113
Smith & Nephew was among Monday’s gainers as takeover speculation was given another airing.
S&N added 1.8 per cent to £11.65 on talk of interest from Johnson & Johnson, whose DePuy orthopaedic subsidiary was pushed to number three in the market for knee implants by Zimmer’s purchase of Biomet.
Not the first time hearing it ... but I still go in.
S&N added 1.8 per cent to £11.65 on talk of interest from Johnson & Johnson, whose DePuy orthopaedic subsidiary was pushed to number three in the market for knee implants by Zimmer’s purchase of Biomet.
Not the first time hearing it ... but I still go in.
